FUCHS SE NA ST O.N./ DE000A3E5D56 /
| 7/5/2024 8:05:27 AM | Chg. +0.450 | Volume | Bid8:57:18 PM | Ask8:57:18 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 33.450EUR | +1.36% | 0 Turnover: 0.000 |
-Bid Size: - | -Ask Size: - | 4.98 bill.EUR | 3.32% | 15.91 |
GlobeNewswire
5/9
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea E...
GlobeNewswire
5/8
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program M...
GlobeNewswire
5/7
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
5/2
insightsoftware Recognized as DACH Region Market Leader for Sixth Consecutive Year in BARC Score Fin...
GlobeNewswire
4/10
BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Rese...
GlobeNewswire
3/19
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full...
GlobeNewswire
3/12
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive...
GlobeNewswire
3/7
American Institutes for Research Education Experts to Present at the Council for Exceptional Childre...
GlobeNewswire
1/30
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...
GlobeNewswire
1/24
Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host...
GlobeNewswire
12/9/2023
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
11/13/2023
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portf...
GlobeNewswire
11/6/2023
Sermonix Pharmaceuticals Announces JCO Precision Oncology Publication of Case Report on a Complete R...
GlobeNewswire
10/19/2023
CIO Leadership: The Visionary Leadership Needed to Drive an Enterprise Generative AI Strategy will P...
